Committed to patients with
breakthrough science

Drugging The Undruggable

Many desirable drug targets in cancer, infectious disease, sepsis, and neurological diseases fall into this category, including the RAS family and MYC oncogenes, cancer stem cells, PI3K, NF-kB, signaling pathways, transcription factors, P53, and many others. Pharmacologically targeting these intractable proteins with non-toxic drugs is no longer a key challenge. We have combined our years of research and understanding of these undruggable targets in order to create innovative technologies to push the boundaries for preventive and curative medicines.

Discover More

Revolutionary Drug Design and Technology

The advantages and unique attributes associated with our small molecules are their innate ability to hone in on specific molecular drivers of various diseases, while limiting the side effects that can affect healthy tissues. Our Small molecules are designed to target multiple mutated genes, signaling pathways, with just one single agent, and without toxicity. We use our deep molecular and chemical know-how to do the impossible for patients.

Discover More